Illumina Inc

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries. Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.

ILMN

Financials

Illumina Inc

Noticias

Illumina se asocia con D3b en iniciativa de datos genómicos pediátricos

Three Best Genomics Stocks for Your Portfolio in 2026

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report?

Illumina Stock: Competitive Threats Priced In (NASDAQ:ILMN)

REGN or ILMN: Which Is the Better Value Stock Right Now?

Illumina suma a King a su junta mientras tres consejeros se retiran

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Argus eleva el precio objetivo de Illumina a 145 dólares por nuevos productos

ILMN Stock Gains Following Expanded Collaboration With Labcorp

Illumina y Labcorp amplían colaboración en pruebas de cáncer

Illumina se asocia con Veritas para ofrecer secuenciación genómica vía aseguradoras